📰 Evelop News
Page 90 - Evelop News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evelop. Real-time updates on events, politics, business and more.
July 14, 2022
Karnataka is moving aggressively to set in place a robust civil aviation system to boost the states economy and plans are afoot to develop 9 water aerodromes in the state, Infrastructure Development Minister V
July 14, 2022
Vulcan Energy Resources Ltd has entered into a binding collaboration agreement with Enel Green Power EGP to develop its Italian project
July 13, 2022
BOULOGNE-BILLANCOURT (dpa-AFX) - French automaker Renault Group (RNT.L) and Vitesco Technologies, a manufacturer of modern drive technologies and electrification solutions, signed a strategic partnership
July 13, 2022
Scientists of the Indian Institute of Science (IISc) in collaboration with researchers from the CSIR-Institute of Microbial Technology developed a novel mechanism to inactivate COVID (SARS-CoV-2) virus by blocking their entry to cells and reducing infection ability, said the Ministry of Science and Technology on Wednesday.
July 9, 2022
Hindustan Aeronautics Limited (HAL) and France-based Safran Helicopter Engines have signed an agreement to create a new joint venture intended to develop helicopter engines.
July 9, 2022
A recent study found that male dogs are four to five times more likely than female dogs to develop the oro-nasal variant of a canine transmissible venereal tumour.
July 9, 2022
A group of Singaporean scientists have developed a bio-functional thermogel, a type of synthetic polymer, to prevent retinal scarring caused by failed retinal detachment repair surgery, according to a new study.
July 9, 2022
Union Minister of Education Dharmendra Pradhan on Saturday asserted that in order to prepare 21st century-ready students, we need to develop forward-looking, responsive, and world-class higher education institutions.
July 7, 2022
Scientists have developed a new technique for imaging mRNA molecules in the brains of living mice
July 7, 2022
Provides additional opportunity for Exelixis to further expand its biotherapeutics development pipeline by combining its tumor-specific targeting approaches with Ryvu's STING agonist technology, which